Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Weight Loss, Ozempic and Wegovy
IBX will no longer cover drugs like Ozempic when they are prescribed solely for weight loss
GLP-1 receptor agonists, which can cost around $1,300 a month, have caused an increase in premiums that “affect all members, whether they utilize weight loss drugs or not,” IBX said in a statement.
“Looking Good, Santa”: Elon Musk Admits To Using Mounjaro For Weight Loss In “Ozempic Santa” Post
Elon Musk uses the weight-loss drug Mounjaro, he newly revealed, as he jokingly referred to himself as “Ozempic Santa” in a Santa suit. Taking to the social media platform he owns, X (formerly known as Twitter),
What to Know About Ozempic, Wegovy and the New Weight-Loss Market
Ozempic is a drug for diabetes, but it's also being used off-label for weight loss. Its active ingredient has inspired a new class of weight-loss drugs.
1h
Better Buy: Eli Lilly vs. Novo Nordisk. The Answer Is Becoming Abundantly More Clear.
Eli Lilly and Novo Nordisk are the two biggest names in the pharmaceutical sector, but I see one as the clear-cut winner for ...
Opinion
2d
Opinion
We've Accepted Wegovy and Zepbound. The Next Phase Is Harder.
An international committee of experts will release an interim report in early 2025 outlining criteria for diagnosing ...
13d
on MSN
For people who couldn’t get Ozempic or Wegovy, 2025 could be your year (if you can afford it)
It’s quickly become evident that GLP-1 drugs for diabetes, weight loss, and more are the new wonder drugs—if only people ...
3h
Down 19% in 1 Day, Is Novo Nordisk Stock Still a Buy?
Amidst a race with its competitors to produce the next smash-hit weight loss drug, Novo Nordisk 's ( NVO 0.15%) stock crashed ...
dailymemphian
3d
‘It’s bonkers’ — how Ozempic, Wegovy change lives of those who struggle to lose weight
Unless the government intervenes to lower the price or forces insurers to cover the drugs, they will remain out of range for ...
Opinion
Alaska Dispatch News
17h
Opinion
Opinion: We’ve accepted Wegovy and Zepbound. The next phase is harder.
An international committee of experts will release an interim report in early 2025 outlining criteria for diagnosing ...
New Scientist
23h
Why US obesity rates fell for the first time in decades
After years of rising obesity rates in the US, the numbers dipped slightly during 2023, though experts disagree about the ...
4d
on MSN
Novo Nordisk stock price takes a tumble after the Wegovy maker’s next-generation weight-loss drug underwhelms
Results for its new CagriSema drug, while promising, fell below expectations, sending shares of the pharmaceutical giant down ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Related topics
Ozempic
weight loss
Novo Nordisk
Food and Drug Administration
Zepbound
Feedback